[PRESENT TRENDS IN THE THERAPY OF HYPERFIBRINOLYTIC STATES].
D000305:Adrenal Cortex Hormones; D000347:Afibrinogenemia; D000614:Aminocaproates; D015119:Aminocaproic Acid; D000925:Anticoagulants; D001803:Blood Transfusion; D004791:Enzyme Inhibitors; D005342:Fibrinolysis; D006470:Hemorrhage; D007610:Kallikreins; D010336:Pathology; D010455:Peptides; D011693:Purpura; D011696:Purpura, Thrombocytopenic; D012771:Shock, Hemorrhagic; D014357:Trypsin
D000305:Adrenal Cortex Hormones; D000614:Aminocaproates; D000925:Anticoagulants; D004791:Enzyme Inhibitors; D010455:Peptides; D007610:Kallikreins; D014357:Trypsin; D015119:Aminocaproic Acid
ADRENAL CORTEX HORMONES; AFIBRINOGENEMIA; AMINOCAPROIC ACID; ANTICOAGULANTS; BLOOD TRANSFUSION; ENZYME INHIBITORS; FIBRINOLYSIS; HEMORRHAGE; KALLIKREIN; PATHOLOGY; PEPTIDES; PURPURA; PURPURA, THROMBOPENIC; REVIEW; SHOCK, HEMORRHAGIC; TRYPSIN
ATTUALI INDIRIZZI DI TERAPIA NEGLI STATI IPERFIBRINOLITICI.